Allweiss P, Braunstein G D, Katz A, Waxman A
J Nucl Med. 1984 Jul;25(7):755-8.
During a 4-yr period, ten of 87 patients (11.5%) who received therapeutic doses of radioactive iodine (I-131) for thyroid carcinoma developed acute and/or chronic sialadenitis involving the parotid (five patients) or submandibular (four patients) glands, or both (one patient). Nine of the 10 patients had received prior I-131 therapy; the precipitating I-131 dose varied between 10 and 164 mCi. Onset of symptoms occurred between 1 day and 6 mo following therapy and the duration varied from 3 wk to 21/2 yr. This complication occurs more often than has been appreciated.
在4年期间，87例接受治疗剂量放射性碘（I-131）治疗甲状腺癌的患者中有10例（11.5%）发生了急性和/或慢性涎腺炎，累及腮腺（5例）或颌下腺（4例），或两者均累及（1例）。10例患者中有9例曾接受过I-131治疗；诱发I-131剂量在10至164毫居里之间。症状在治疗后1天至6个月之间出现，持续时间从3周至2年半不等。这种并发症的发生率比人们意识到的要高。
